Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A heart septal defect refers to a congenital malformation where there is a hole in the wall (septum) separating either the top (atria) or bottom (ventricles) chambers of the heart. The two most common forms are **ventricular septal defect (VSD)** and **atrial septal defect (ASD)**. These defects allow abnormal blood flow between chambers, leading to inefficient circulation, potential overloading of the lungs, and possible long-term complications including heart failure, pulmonary hypertension, arrhythmia, and stroke[1][2][4][5]. Diagnosis often involves detection of a heart murmur and imaging with echocardiogram. Small defects may close spontaneously; larger ones often require surgical or device-based closure. Medicines manage symptoms but do not close the defect[1][2][5].
Symptomatic relief (e.g., fluid reduction, blood pressure control); closure via surgery or device occlusion
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heart septal defect (null).